NAA10 (N-α-乙基转移酶10):在发育,疾病和癌症中的多功能调节剂
Zeng Quan Yang1,2, Ion John Campeanu2, Ivan Lopez2
1Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA.
Cells
|June 25, 2025
概括
N-α-乙转移酶10 (NAA10) 对于蛋白质乙化至关重要,并与奥格登综合征等发育障碍有关. 它在癌症中的失调影响瘤的进展,突出其治疗潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- NAA10是NatA复合物的催化子单元,对于人类蛋白质的40-50%的N终端乙化至关重要.
- NAA10还可乙化内部氨酸残留物,并通过蛋白质相互作用发挥非催化调节作用.
- 致病性NAA10变体导致奥格登综合征,这是一个具有神经发育,心脏和面问题的发育障碍.
研究的目的:
- 审查NAA10的结构,机制和功能.
- 探索NAA10在人类疾病和癌症中的作用.
- 讨论NAA10的治疗策略和未来研究.
主要方法:
- 对NAA10的结构,功能和疾病相关性的文献综述.
- 在 silico 泛癌分析中评估临床意义和途径.
- 对NAA10的生理和病理作用的当前知识的综合.
主要成果:
- 在N端和内部乙化中NAA10的双重作用,以及非催化功能.
- NAA10失调与癌症攻击性和预后不佳的关联.
- 通过泛癌分析识别潜在的下游途径和治疗点.
结论:
- NAA10是健康和疾病,特别是癌症中重要的酶.
- 针对NAA10提供了治疗机会,但也带来了挑战.
- 需要进一步的研究来充分阐明NAA10的多方面的作用.
更多相关视频
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
7.7K
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
7.0K
相关概念视频
Notch Signaling Pathway
4.5K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.5K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Master Transcription Regulators
7.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Canonical Wnt Signaling Pathway
9.0K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.0K
